Solo-GP Celestine Schnugg treats founders as scientist-protagonists, concentrates on frontier genomics, machine intelligence, underwrites elevated technical/space risk, frequently backs underrepresented leaders, alongside convenes secret meetups. A key differentiator: fresh chemistries and space.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Formative-stage technical frontier specialist that co-invests with top global funds, led by ex-senior Microsoft strategy executives providing deep platform strategy and M&A expertise and a strong early-unicorn established record. The firm continues to build its presence across the venture capital landscape.
Targets concept-stage software-plus-physical goods emerging ventures, acting as a hands-on product partner with veteran hardware engineers, a million-dollar prototyping shop, and direct guidance on design, manufacturing and fundraising. With a disciplined investment approach, the team drives value for both founders and investors.
Physician-led, immigrant-founded VC built by third-culture founders using cross-cultural insight to back healthcare founders with lived experience and target structural health inequities over generic digital tools. With a disciplined investment approach, the team drives value for both founders and investors.
Is dedicated to companies empowering informed, connected health consumers and building system-level resilience to improve outcomes, experiences, and lower healthcare costs. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Early investor in AI applications and infrastructure, led by active AI practitioners Socher, Manning, and Goldbloom who continue hands-on research and company-building, providing domain expertise and founder partnership. The firm continues to build its presence across the venture capital landscape.
Thesis-driven TechBio fund oriented toward engineering, computation, and biology, operating a BIOS community platform with podcasts, events, content, and a year-long Venture Residency training future TechBio VCs. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
